Skip to main content

Using Rapid Clozapine Blood Levels to Improve Patient Management – 30 Years of Clozapine Experience

Recorded at the April 2023 Annual Meeting of the American Association of Psychiatric Pharmacists

More InfoView More Webinars


Clozapine is the only evidence-based antipsychotic option for treatment-resistant schizophrenia and patients with schizophrenia and suicidality. However, using it demands regular monitoring of a patient’s clozapine blood level. The faculty will discuss how a rapid clozapine blood level can improve managing patients’ care and how to interpret values against the patient’s response and tolerability. Professor Taylor will share his 30 years of experience working with clozapine, implementing a rapid clozapine blood test and blood level guidance that he provides within the South London and Maudsley Trust.

Presenting Faculty:

David Taylor, PhD, FRPharmS, FRCPsych (Hon)

  • Director of Pharmacy and Pathology
    South London and Maudsley NHS Foundation Trust, London, UK
  • Professor of Psychopharmacology
    Institute of Pharmaceutical Science, King’s College, London, UK
  • Editor-in-Chief
    Therapeutic Advances in Psychopharmacology

Jonathan G. Leung, PharmD, BCPS, BCPP

  • Pharmacist
    Department of Pharmacy, Mayo Clinic, Rochester, MN

Megan Ehret, PharmD, MS, BCPP

  • Professor
    Department of Practice, Sciences, and Health Outcomes Research
    University of Maryland School of Pharmacy
  • SMI Adviser, Pharmacist Consultant

Additional Resources:

For additional handouts, questions, or inquiries, please contact or enter your email below!

Leave a Reply